Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
bluebird bio Stock Forecast NASDAQ:BLUE
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-17 | -10.45% | Morgan Stanley | $5.00 $3.00 | Maintains | Underweight |
| 2022-05-10 | -10.45% | Barclays | $4.00 $3.00 | Maintains | Underweight |
| 2022-04-06 | 138.81% | SVB Leerink | $10.00 $8.00 | Maintains | Market Perform |
| 2022-04-06 | - | Cowen & Co. | - | Downgrades | Outperform Market Perform |
| 2022-03-08 | 138.81% | Wells Fargo | $12.00 $8.00 | Maintains | Equal-Weight |
| 2022-03-07 | 49.25% | Morgan Stanley | $6.00 $5.00 | Maintains | Underweight |
| 2022-03-07 | 19.4% | Barclays | $13.00 $4.00 | Downgrades | Equal-Weight Underweight |
| 2022-03-07 | 198.51% | SVB Leerink | $11.00 $10.00 | Maintains | Market Perform |
| 2022-01-06 | 198.51% | Morgan Stanley | $11.00 $10.00 | Maintains | Underweight |
| 2021-11-08 | 228.36% | Morgan Stanley | $11.00 | Downgrades | Equal-Weight Underweight |
| 2021-11-08 | 198.51% | Goldman Sachs | $23.00 $10.00 | Downgrades | Neutral Sell |
| 2021-11-08 | 288.06% | Barclays | $20.00 $13.00 | Maintains | Equal-Weight |
| 2021-09-22 | 586.57% | Mizuho | $29.00 $23.00 | Maintains | Buy |
| 2021-08-10 | 646.27% | Wells Fargo | $60.00 $25.00 | Downgrades | Overweight Equal-Weight |
| 2021-08-10 | 497.01% | Canaccord Genuity | $86.00 $20.00 | Downgrades | Buy Hold |
| 2021-08-10 | 586.57% | Goldman Sachs | $63.00 $23.00 | Downgrades | Buy Neutral |
| 2021-07-16 | 944.78% | Morgan Stanley | $36.00 $35.00 | Maintains | Equal-Weight |
| 2021-07-01 | 944.78% | Berenberg | $35.00 | Downgrades | Buy Hold |
| 2021-04-19 | 974.63% | Morgan Stanley | $45.00 $36.00 | Maintains | Equal-Weight |
| 2021-03-29 | 2049.25% | SVB Leerink | $69.00 $72.00 | Maintains | Outperform |
| 2021-03-10 | 1959.7% | Mizuho | $34.00 $69.00 | Upgrades | Neutral Buy |
| 2021-03-02 | 1243.28% | Morgan Stanley | $50.00 $45.00 | Maintains | Equal-Weight |
| 2021-02-17 | 1064.18% | JP Morgan | $76.00 $39.00 | Downgrades | Overweight Neutral |
| 2020-11-11 | 1810.45% | Berenberg | $64.00 | Initiates Coverage On | Buy |
| 2020-11-11 | 1392.54% | Morgan Stanley | $68.00 $50.00 | Maintains | Equal-Weight |
| 2020-11-05 | 1571.64% | BMO Capital | $56.00 | Downgrades | Outperform Market Perform |
| 2020-11-05 | 1541.79% | Piper Sandler | $70.00 $55.00 | Maintains | Neutral |
| 2020-11-05 | 2317.91% | B of A Securities | $100.00 $81.00 | Maintains | Buy |
| 2020-11-05 | 2855.22% | SVB Leerink | $133.00 $99.00 | Maintains | Outperform |
| 2020-10-20 | 3571.64% | Mizuho | $123.00 | Initiates Coverage On | Buy |
| 2020-08-10 | 1929.85% | Morgan Stanley | $73.00 $68.00 | Maintains | Equal-Weight |
| 2020-08-06 | 2317.91% | Wedbush | $89.00 $81.00 | Maintains | Outperform |
| 2020-08-06 | 3123.88% | BMO Capital | $112.00 $108.00 | Maintains | Outperform |
| 2020-07-13 | 2885.07% | B of A Securities | $104.00 $100.00 | Maintains | Buy |
| 2020-06-12 | 3870.15% | SVB Leerink | $129.00 $133.00 | Maintains | Outperform |
| 2020-05-28 | 2079.1% | Morgan Stanley | $69.00 $73.00 | Maintains | Equal-Weight |
| 2020-05-28 | 3750.75% | SVB Leerink | $125.00 $129.00 | Maintains | Outperform |
| 2020-05-13 | 2885.07% | RBC Capital | $100.00 | Initiates Coverage On | Outperform |
| 2020-05-12 | 3243.28% | BMO Capital | $107.00 $112.00 | Maintains | Outperform |
| 2020-04-15 | 1959.7% | Morgan Stanley | $92.00 $69.00 | Maintains | Equal-Weight |
| 2020-03-27 | 1989.55% | Stifel | $94.00 $70.00 | Upgrades | Hold Buy |
| 2020-02-26 | 2646.27% | Morgan Stanley | $100.00 $92.00 | Maintains | Equal-Weight |
| 2020-02-19 | 2705.97% | Stifel | $96.00 $94.00 | Maintains | Hold |
| 2020-02-03 | 2885.07% | Evercore ISI Group | $86.00 $100.00 | Upgrades | In-Line Outperform |
| 2019-12-13 | 3929.85% | Oppenheimer | $135.00 | Upgrades | Perform Outperform |
| 2019-12-09 | 4676.12% | Wells Fargo | $242.00 $160.00 | Maintains | Overweight |
| 2019-11-26 | 3452.24% | SVB Leerink | $119.00 | Upgrades | Market Perform Outperform |
| 2019-11-19 | 2467.16% | Evercore ISI Group | $86.00 | Downgrades | Outperform In-Line |
| 2019-11-04 | - | Wedbush | - | Upgrades | Neutral Outperform |
| 2019-11-01 | 2885.07% | Morgan Stanley | $104.00 $100.00 | Maintains | Equal-Weight |
| 2019-11-01 | 2437.31% | Piper Sandler | $120.00 $85.00 | Maintains | Neutral |
| 2019-10-11 | 3004.48% | Morgan Stanley | $136.00 $104.00 | Maintains | Equal-Weight |
| 2019-10-01 | 3153.73% | Stifel | $109.00 | Initiates Coverage On | Hold |
| 2019-08-12 | - | William Blair | - | Downgrades | Outperform Market Perform |
| 2019-08-06 | 3959.7% | Morgan Stanley | $143.00 $136.00 | Maintains | Equal-Weight |
| 2019-06-18 | 4676.12% | Maxim Group | $160.00 | Upgrades | Hold Buy |
| 2019-06-17 | 4765.67% | BMO Capital | $191.00 $163.00 | Maintains | Outperform |
| 2019-05-15 | 3810.45% | Wedbush | $166.00 $131.00 | Downgrades | Outperform Neutral |
BLUE Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -35.11% during the next 3 months and, with a 90% probability hold a price between $1.94 and $2.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-23 | $2.96 | $3.50 | $4.04 |
| 2022-05-24 | $2.92 | $3.46 | $4.00 |
| 2022-05-25 | $2.88 | $3.43 | $3.97 |
| 2022-05-26 | $2.85 | $3.39 | $3.93 |
| 2022-05-27 | $2.81 | $3.35 | $3.89 |
| 2022-05-31 | $2.78 | $3.32 | $3.86 |
| 2022-06-01 | $2.74 | $3.28 | $3.82 |
| 2022-06-02 | $2.70 | $3.24 | $3.78 |
| 2022-06-03 | $2.67 | $3.21 | $3.75 |
| 2022-06-06 | $2.63 | $3.17 | $3.71 |
| 2022-06-07 | $2.60 | $3.14 | $3.68 |
| 2022-06-08 | $2.56 | $3.10 | $3.64 |
| 2022-06-09 | $2.52 | $3.06 | $3.60 |
| 2022-06-10 | $2.49 | $3.03 | $3.57 |
| 2022-06-13 | $2.45 | $2.99 | $3.53 |
| 2022-06-14 | $2.41 | $2.96 | $3.50 |
| 2022-06-15 | $2.38 | $2.92 | $3.46 |
| 2022-06-16 | $2.34 | $2.88 | $3.42 |
| 2022-06-17 | $2.31 | $2.85 | $3.39 |
| 2022-06-21 | $2.27 | $2.81 | $3.35 |
| 2022-06-22 | $2.23 | $2.77 | $3.31 |
| 2022-06-23 | $2.20 | $2.74 | $3.28 |
| 2022-06-24 | $2.16 | $2.70 | $3.24 |
| 2022-06-27 | $2.13 | $2.67 | $3.21 |
| 2022-06-28 | $2.09 | $2.63 | $3.17 |
| 2022-06-29 | $2.05 | $2.59 | $3.13 |
| 2022-06-30 | $2.02 | $2.56 | $3.10 |
| 2022-07-01 | $1.98 | $2.52 | $3.06 |
| 2022-07-05 | $1.95 | $2.49 | $3.03 |
| 2022-07-06 | $1.91 | $2.45 | $2.99 |
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its product candidates include Lenti-D, which is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell di... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
